期刊文献+

葡萄糖激酶基因E339K突变的功能学研究 被引量:2

The functional analysis of glucokinase gene E339K mutation
原文传递
导出
摘要 目的 探讨葡萄糖激酶(GCK)基因E339K突变引起青少年的成年起病型糖尿病2型(MODY2)的分子机制.方法 MODY2家系成员进行葡萄糖耐量试验,测定空腹及负荷后2h血糖、糖化血红蛋白、空腹胰岛素.PCR扩增GCK基因并直接测序.构建E339K突变质粒.表达并纯化野生型和突变型GCK蛋白.酶偶联分析法进行功能学测定.结果 与非突变成员相比,突变者空腹、负荷后2 h血糖、糖化血红蛋白更高;空腹胰岛素、胰岛素分泌指数明显降低;胰岛素抵抗指数无显著差异.突变导致GCK蛋白产量降低[(12.7±1.72)mg/L比(16.2±2.65)mg/L,P<0.01];当ATP为饱和浓度时酶促反应速度达到1/2最大反应速度时的葡萄糖浓度(S0.5)[(13.96±1.89)mmol/L比(5.92±0.99)mmol/L,P<0.001]和当葡萄糖为饱和浓度时酶促反应速度达到1/2最大反应速度时的ATP浓度(ATP-Km)显著升高[(3.27±1.14)mmol/L比(0.30±0.09)mmol/L,P<0.001];GCK对葡萄糖的催化常数显著下降[(1.62±0.35)/s比(25.18±2.10)/s,P<0.001];热稳定性下降,表现为在相对更低的孵育温度下或同一温度相对更短的时间内活性丧失.结论 GCK基因E339K突变导致的蛋白表达下降、对葡萄糖和ATP的亲和力下降以及热稳定性下降是造成胰岛β细胞分泌胰岛素减少进而发生MODY2的可能分子机制. Objective To explore the molecular mechanisms of glucokinase (GCK) E339K mutation resulting in maturity-onset diabetes of the young-2 (MODY2).Methods Fasting plasma glucose (FPG), oral glucose tolerance test (OGTT) overload 2 h glucose (2hPG), glycosylated hemoglobin Alc (HbAlc) and fasting insulin (FIns) level were measured, respectively.Mutant glutathione S-transferase (GST)-GCK-cDNA was constructed with site-directed mutagenesis.Wild type and mutant GCK protein expressed in E.Coli were purified with affinity chromatography.Enzymatic kinetics and thermal stability were tested with enzyme-coupled analysis.Results Compared with non-mutants, mutants had higher FPG [(6.92 ± 0.95) mmol/L vs (4.70 ± 0.35) mmol/L, P〈0.001], 2hPG [(9.00 ± 1.49 ) mmol/L vs (5.51 ± 0.86) mmol/L,P〈0.001],HbAlc[(6.46 ± 0.69)% vs(4.83 ± 0.30)%,P〈0.01],and lower FIns level [(6.15 ± 1.97 ) mIU/L vs ( 10.79 ± 4.93 ) mIU/L, P 〈 0.01], HOMA-β (34.16 ±3.62 vs 172.53 ± 76.58, P 〈 0.001 ).This mutation induced lower protein yield [( 12.7 ±1.72) mg/L vs ( 16.2 ± 2.65 ) mg/L, P 〈 0.01], lower appetency for glucose [S0.5: ( 13.96 ± 1.89)mmol/L vs (5.92±0.99)mmol/L, P〈0.001] and ATP [Km:(3.27 ±1.14) mmol/L vs (0.30±0.09)mmol/L, P〈0.001], lower catalytic ability [Kcat:(1.62 ±0.35)/s vs (25.18 ±2.10)/s, P〈0.001].It also showed protein thermal instability.Conclusion Glucokinase gene E339K mutation promotes the development of MODY2 by affecting protein yield and protein stability as well as the enzymatic kinetics of GCK.
出处 《中华内科杂志》 CAS CSCD 北大核心 2010年第7期582-586,共5页 Chinese Journal of Internal Medicine
基金 教育部博士点基金(200805580070) 教育部博士后基金(20060390754) 广东省自然科学基金(8151008901000196) 广东省医学科学基金(B2008045)
关键词 葡糖激酶 突变 功能学研究 Glucokinase Mutation Functional analysis
  • 相关文献

参考文献22

  • 1Galán M,Vincent O,Poncero I,et al.Effects of novel maturityonset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability.Biochem J,2006,393Pt 1:389-396.
  • 2Matschinsky FM.Regulation of pancreatic beta-cell glucokinase:from basics to therapeutics.Diabetes,2002,51 Suppl 3:S394-404.
  • 3Vionnet N,Stoffel M,Takeda J,et al.Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus.Nature,1992,256:721-722.
  • 4蔡梦茵,梁华,沈云峰,毕艳,严晋华,徐芬,翁建平.一个新的葡萄糖激酶基因-E339K突变导致的中国人青少年发病的成年型糖尿病2型家系[J].中华内科杂志,2009,48(9):720-723. 被引量:6
  • 5Liang Y,Kesavan P,Wang L,et al.Variable effects of maturity-onset-diabetes-of-young (MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme.Biochem J,1995,309:167-173.
  • 6Kesavan P,Wang L,Davis E,et al.Structural instability of mutant beta-cell glucokinase:implications for the molecular pathogenesis of maturity-onset diabetes of the young (type-2).Biochem J,1997,322:57-63.
  • 7Davis EA,Cuesta-Mu(n)oz A,Raoul M,et al.Mutants of glucokinase cause hypoglycaemia-and hyperglycaemia syndromes and their analysis illuminates fundamental quantitative concepts of glucose homeostasis.Diabetologia,1999,42:1175-1186.
  • 8Stride A,Ellard S,Clark P,et al.Beta-cell dysfunction,insulin sensitivity,and glycosuria precede diabetes in hepatocyte nuclear factor-1 alpha mutation carriers.Diabetes Care,2005,28:1751-1756.
  • 9Winckler W,Burtt NP,Holmkvist J,et al.Association of common variation in the HNF1 alpha gene region with risk of type 2 diabetes.Diabetes,2005,54:2336-2342.
  • 10Matschinsky FM.Glucokinase,glucose homeostasis,and diabetes mellitus.Curr Diab Rep,2005,5:171-176.

二级参考文献20

  • 1Gat-Yablonski G, Shalitin S, Phillip M. Maturity onset diabetes of the young--review. Pediatr Endocrinol Rev, 2006, 3 Suppl 3 : 514 - 520.
  • 2Yamagata K, Furuta H, Oda N, et al. Mutations in the hepatocyte nuclear factor-4-alpha gene in maturity-onset diabetes of the young ( MODY1 ). Nature, 1996, 384:458-460.
  • 3Njolstad PR, Sovik O, Cuesta-Munoz A, et al. Neonatal diabetes mellitus due to complete glucokinase deficiency. N Engl J Med, 2001, 344 : 1588-1592.
  • 4Yamagata K, Oda N, Kaisaki PJ, et al. Mutations in the hepatocyte nuclear factor-1-alpha gene in maturity-onset diabetes of the young (MODY3). Nature, 1996, 384:455-458.
  • 5Stoffers DA, Ferrer J, Clarke WL, et al. Early-onset type 2 diabetes mellitus ( MODY4 ) linked to IPF1. Nat Genet, 1997, 17:138-139.
  • 6Horikawa Y, lwasaki N, Hara M, et al. Mutations in hepatocyte nuclear factor 113 gene (TCF2) associated with MODY. Nat Genet, 1997, 17:384-385.
  • 7Malecki MT, Jhala US, Antonellis A, et al. Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus. Nat Genet, 1999, 23:323-328.
  • 8Hattersley AT, Turner RC, Permutt MA, et al. Linkage of type 2 diabetes to the glucokinase gene. Lancet, 1992, 339 : 1307-1310.
  • 9Martin D, Bellanne-Chantelot C, Deschamps I, et al. Long-term follow-up of oral glucose tolerance test-derived glucose tolerance and insulin secretion and insulin sensitivity indexes in subjects with glucokinase mutations(MODY2). Diabetes Care, 2008, 31 : 1321-1323.
  • 10Garin I, Rica I, Estalella I, et al. Haploinsufficiency at GCK gene is not a frequent event in MODY2 patients. Clin Endocrinol ( Oxf), 2008, 68:873-878.

共引文献5

同被引文献27

  • 1KanakattiSR, PihokerC, DolanLM, et al. Permanent neonatal diabetes mellitus: prevalence and genetic diagnosis in the SEARCH for Diabetes in Youth Study[J]. Pediatr Diabetes, 2013, 14(3):174-180. DOI: 10.1111/pedi.12003.
  • 2NaylorRN, GreeleySA, BellGI, et al. Genetics and pathophysiology of neonatal diabetes mellitus[J]. J Diabetes Investig, 2011, 2(3):158-169.DOI:10.1111/j.2040-124.2011.00106.x.
  • 3OsbakKK, ColcloughK, Saint-MartinC, et al. Update on mutations in glucokinase (GCK), which cause maturity-onset diabetes of the young, permanent neonatal diabetes, and hyperinsulinemic hypoglycemia[J]. Hum Mutat, 2009, 30(11):1512-1526. DOI: 10.1002/humu.21110.
  • 4LiangY, KesavanP, WangLQ, et al. Variable effects of maturity-onset-diabetes-of-youth(MODY)-associated glucokinase mutations on substrate interactions and stability of the enzyme[J]. Biochem J, 1995, 309(Pt 1):167-173.
  • 5GalanM, VincentO, RonceroI, et al. Effects of novel maturity-onset diabetes of the young (MODY)-associated mutations on glucokinase activity and protein stability[J]. Biochem J, 2006, 393(Pt 1):389-396.
  • 6EllardS, BeardsF, AllenLI, et al. A high prevalence of glucokinase mutations in gestational diabetic subjects selected by clinical criteria[J]. Diabetologia, 2000, 43(2):250-253.
  • 7HwangJS, ShinCH, YangSW, et al. Genetic and clinical characteristics of Korean maturity-onset diabetes of the young (MODY) patients[J]. Diabetes Res Clin Pract, 2006, 74(1):75-81.
  • 8Sagen JV, BjorkhaugL, MolnesJ, et al. Diagnostic screening of MODY2/GCK mutations in the Norwegian MODY Registry[J]. Pediatr Diabetes, 2008, 9(5):442-449.DOI:10.1111/j.1399-5448.2008.00399.x.
  • 9MarquardJ, PalladinoAA, StanleyCA, et al. Rare forms of congenital hyperinsulinism[J]. Semin Pediatr Surg, 2011, 20(1):38-44. DOI: 10.1053/j.sempedsurg.2010.10.006.
  • 10StrideA, VaxillaireM, TuomiT, et al. The genetic abnormality in the beta cell determines the response to an oral glucose load[J]. Diabetologia, 2002, 45(3):427-435.

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部